TRIB Projected Dividend Yield
Trinity Biotech Plc ( NASDAQ : TRIB )Trinity Biotech develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Co. is also a provider of raw materials to the life sciences and research industries globally. Co. markets its portfolio of products to customers through its own sales force and a network of international distributors and partners. The brand names of the products of Co. include UniGold, Recombigen, MarDx, FlexTrans, Premier, Ultr, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ, and Captia. 20 YEAR PERFORMANCE RESULTS |
TRIB Dividend History Detail TRIB Dividend News TRIB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |